Physician

Steven M Bromley, MD

According to 2025 Medicare claims, Steven Bromley, MD (NPI: 1962591586) practices neurology in the Camden, NJ market, with the plurality of this provider's patient population coming from Burlington, NJ. This provider's primary affiliated billing organization is BROMLEY NEUROLOGY, PC (NPI: 1437313368; TIN: 83-0366915) and primary practice location at 08106-1659.

Bromley's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 500 traditional Medicare patients, billed 115,614 HCPCS/CPT codes, and received $3,192,378 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 2,821 prescription claims across 422 beneficiaries totaling $5,644,533 in drug costs, led by Cortrophin (Corticotropin). 2019 DME data shows 22 claims. Open Payments data shows 669 records totaling $305,299. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $101,538 to $3,192,378. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,349 and ending at $3,749.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	513	1,046	$101,538
2016	383	31,312	$1,018,906
2017	279	67,666	$1,775,894
2018	266	105,216	$3,334,355
2019	293	91,232	$3,567,917
2020	343	102,739	$5,329,489
2021	364	114,553	$6,928,781
2022	408	161,953	$8,653,974
2023	450	121,252	$5,746,743
2024	500	115,614	$3,192,378

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	363	4,562	$4,937,263
2016	375	3,630	$5,217,981
2017	325	3,485	$5,933,426
2018	302	3,079	$5,843,308
2019	293	2,733	$6,281,694
2020	351	2,963	$4,646,775
2021	367	3,462	$4,486,255
2022	366	2,760	$3,872,802
2023	372	2,583	$3,766,092
2024	422	2,821	$5,644,533

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	19	$617
2016	N/R	15	$1,691
2017	N/R	12	$171
2018	N/R	14	$129
2019	N/R	22	$1,352
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	120	120	$165
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	325	536	$146
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	205	260	$99
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	72	494	$55
J2919	Injection, methylprednisolone sodium succinate, 5 mg	56	10,034	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cortrophin	Corticotropin	27	399	$2,858,706
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	28	788	$391,655
Ingrezza	Valbenazine Tosylate	28	840	$326,065
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	38	1,064	$301,283
Austedo	Deutetrabenazine	21	630	$204,761

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	669	$305,299	Otsuka America Pharmaceutical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Steven M. Bromley, MD?

Tedicare shows public-source Medicare data for Steven M. Bromley, MD (NPI 1962591586), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Steven M. Bromley, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Steven M. Bromley, MD?

Steven M. Bromley, MD is linked to BROMLEY NEUROLOGY, PC (billing NPI 1437313368) in the available physician profile data.

Does Steven M. Bromley, MD have Open Payments data?

Steven M. Bromley, MD has 669 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.